Annual Cash & Cash Equivalents
$23.14 M
-$4.47 M-16.20%
31 December 2023
Summary:
ClearPoint Neuro annual cash & cash equivalents is currently $23.14 million, with the most recent change of -$4.47 million (-16.20%) on 31 December 2023. During the last 3 years, it has risen by +$3.04 million (+15.13%). CLPT annual cash & cash equivalents is now -57.23% below its all-time high of $54.11 million, reached on 31 December 2021.CLPT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$21.57 M
-$11.27 M-34.32%
30 September 2024
Summary:
ClearPoint Neuro quarterly cash and cash equivalents is currently $21.57 million, with the most recent change of -$11.27 million (-34.32%) on 30 September 2024. Over the past year, it has dropped by -$2.77 million (-11.38%). CLPT quarterly cash and cash equivalents is now -66.74% below its all-time high of $64.86 million, reached on 31 March 2021.CLPT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLPT Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.2% | -11.4% |
3 y3 years | +15.1% | -62.6% |
5 y5 years | +646.2% | +246.0% |
CLPT Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -57.2% | +15.1% | -62.6% | +15.3% |
5 y | 5 years | -57.2% | +646.2% | -66.7% | +278.7% |
alltime | all time | -57.2% | >+9999.0% | -66.7% | >+9999.0% |
ClearPoint Neuro Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $21.57 M(-34.3%) |
June 2024 | - | $32.84 M(-7.1%) |
Mar 2024 | - | $35.35 M(+52.8%) |
Dec 2023 | $23.14 M(-16.2%) | $23.14 M(-4.9%) |
Sept 2023 | - | $24.34 M(-8.0%) |
June 2023 | - | $26.46 M(+21.4%) |
Mar 2023 | - | $21.79 M(-21.1%) |
Dec 2022 | $27.61 M(-49.0%) | $27.61 M(+47.6%) |
Sept 2022 | - | $18.71 M(-20.5%) |
June 2022 | - | $23.52 M(-52.6%) |
Mar 2022 | - | $49.66 M(-8.2%) |
Dec 2021 | $54.11 M(+169.2%) | $54.11 M(-6.1%) |
Sept 2021 | - | $57.65 M(-6.3%) |
June 2021 | - | $61.52 M(-5.1%) |
Mar 2021 | - | $64.86 M(+222.7%) |
Dec 2020 | $20.10 M(+252.9%) | $20.10 M(+37.0%) |
Sept 2020 | - | $14.67 M(-8.5%) |
June 2020 | - | $16.03 M(-5.6%) |
Mar 2020 | - | $16.98 M(+198.0%) |
Dec 2019 | $5.70 M(+83.7%) | $5.70 M(-8.6%) |
Sept 2019 | - | $6.24 M(-16.4%) |
June 2019 | - | $7.46 M(+199.5%) |
Mar 2019 | - | $2.49 M(-19.7%) |
Dec 2018 | $3.10 M | $3.10 M(-16.4%) |
Sept 2018 | - | $3.71 M(-44.6%) |
Date | Annual | Quarterly |
---|---|---|
June 2018 | - | $6.70 M(-10.9%) |
Mar 2018 | - | $7.51 M(-19.1%) |
Dec 2017 | $9.29 M(+180.2%) | $9.29 M(-15.8%) |
Sept 2017 | - | $11.03 M(-13.4%) |
June 2017 | - | $12.74 M(+546.9%) |
Mar 2017 | - | $1.97 M(-40.6%) |
Dec 2016 | $3.32 M(-38.7%) | $3.32 M(-25.2%) |
Sept 2016 | - | $4.43 M(+119.9%) |
June 2016 | - | $2.02 M(-43.7%) |
Mar 2016 | - | $3.58 M(-33.8%) |
Dec 2015 | $5.41 M(-41.5%) | $5.41 M(+192.1%) |
Sept 2015 | - | $1.85 M(-47.4%) |
June 2015 | - | $3.52 M(-45.3%) |
Mar 2015 | - | $6.44 M(-30.4%) |
Dec 2014 | $9.24 M(+162.9%) | $9.24 M(+387.9%) |
Sept 2014 | - | $1.89 M(-53.5%) |
June 2014 | - | $4.08 M(-29.7%) |
Mar 2014 | - | $5.80 M(+65.0%) |
Dec 2013 | $3.52 M(+117.0%) | $3.52 M(-30.1%) |
Sept 2013 | - | $5.03 M(-27.9%) |
June 2013 | - | $6.98 M(-24.1%) |
Mar 2013 | - | $9.20 M(+467.8%) |
Dec 2012 | $1.62 M(+1013.4%) | $1.62 M(-57.2%) |
Sept 2012 | - | $3.79 M(+209.7%) |
June 2012 | - | $1.22 M(+740.5%) |
Dec 2011 | $145.50 K | $145.50 K |
FAQ
- What is ClearPoint Neuro annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ClearPoint Neuro?
- What is ClearPoint Neuro annual cash & cash equivalents year-on-year change?
- What is ClearPoint Neuro quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly cash and cash equivalents year-on-year change?
What is ClearPoint Neuro annual cash & cash equivalents?
The current annual cash & cash equivalents of CLPT is $23.14 M
What is the all time high annual cash & cash equivalents for ClearPoint Neuro?
ClearPoint Neuro all-time high annual cash & cash equivalents is $54.11 M
What is ClearPoint Neuro annual cash & cash equivalents year-on-year change?
Over the past year, CLPT annual cash & cash equivalents has changed by -$4.47 M (-16.20%)
What is ClearPoint Neuro quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CLPT is $21.57 M
What is the all time high quarterly cash and cash equivalents for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly cash and cash equivalents is $64.86 M
What is ClearPoint Neuro quarterly cash and cash equivalents year-on-year change?
Over the past year, CLPT quarterly cash and cash equivalents has changed by -$2.77 M (-11.38%)